Submitted by Anonymous (not verified) on 10 June 2025 - 13:25
Human medicines European public assessment report (EPAR): Jyseleca, filgotinib, Date of authorisation: 24/09/2020, Revision: 14, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Jyseleca, filgotinib, Date of authorisation: 24/09/2020, Revision: 14, Status: Authorised